Skip to main content
Ariela Noy, MD, Hematology, New York, NY

ArielaNoyMD

Hematology New York, NY

Lymphoma Service, Division of Hematology, Memorial Sloan-Kettering Center, NY, NY

Overview of Dr. Noy

I am a board-certified hematologist and medical oncologist with a major focus on treating cancers of the lymphoid immune system, in particular lymphomas and certain forms of leukemia. HIV-related lymphomas are one my main areas of interest. To provide the best treatment to each patient with these diseases, I work very closely with a team of expert specialists.

My research interests include HIV-related cancers, especially lymphoma; molecular detection of minimal disease in patients on lymphoma trials; and a variety of other lymphoma-related projects, including new treatments, imaging, and quality of life.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1993 - 1997
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1990 - 1993
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1990

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • CT State Medical License
    CT State Medical License 2024 - 2025
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • NY State Medical License
    NY State Medical License 1991 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
    Ariela Noy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...
    Ariela Noy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma
    Ariela Noy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • You Make the Call: Is Hypogammaglobulinemia Alone an Indication for Treatment for CLL?
    You Make the Call: Is Hypogammaglobulinemia Alone an Indication for Treatment for CLL?November 1st, 2020
  • Expert Q&A: Understanding the Oncogenic Role of HIV in Burkitt Lymphoma
    Expert Q&A: Understanding the Oncogenic Role of HIV in Burkitt LymphomaAugust 27th, 2020
  • Data on Rafael Pharmaceuticals’ CPI-613® (Devimistat) in Patients with Relapsed Burkitt Lymphoma to Be Presented at the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition
    Data on Rafael Pharmaceuticals’ CPI-613® (Devimistat) in Patients with Relapsed Burkitt Lymphoma to Be Presented at the 2019 American Society of Hematology (ASH) Annual Meeting & ExpositionDecember 3rd, 2019
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish, Hebrew

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AvMed Health Open Access
    BCBS Blue Card PPO
    BCBS Florida BlueCare HMO
    BCBS Florida NetworkBlue
    BCBS Florida Preferred Patient Care PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment